Abstract
Since 1973 we have treated T3b-T4 (stage III) breast cancer with various forms of multidisciplinary approaches through prospective trials. The present report analyses the 10-year results of 277 patients. Primary chemotherapy consisted of adriamycin plus vincristine given for three or four cycles prior to high-energy irradiation or surgery. In 205 of 277 (74%) additional chemotherapy was planned following the local-regional modality. Primary chemotherapy yielded complete plus partial remission in 62% (CR 7%). Long-term freedom from progression and overall survival were significantly improved by the addition of chemotherapy following local-regional treatment (radiotherapy or surgery). Further chemotherapy was able to significantly affect treatment outcome when it was analyzed both singly and in the presence of other prognostic variables. Thus, in our experience, the variables significantly affecting the 10-year results were represented by duration of treatment and tumor cell burden expressed by size of primary malignancy and clinical nodal status. Locally advanced breast cancer appears a pleomorphic disease difficult to control over a long period of time because of its frequent presentation with bulky tumor and the very high risk of disseminated micrometastases. Thus, the management of this stage of disease almost invariably requires a multidisciplinary approach.
This is a preview of subscription content, log in via an institution to check access.
References
Haagensen CD, Stout AP: Carcinoma of the breast. II. Criteria of operability. Ann Surg 118: 859–870, 1943
Haagensen CD: Diseases of the Breast, 2nd ed. WB Saunders, Philadelphia, 1971
Union Internationale Contre le Cancer (UICC): TNM classification of malignant tumors, 3rd ed. Geneva, 1978
Canellos GP: The treatment of locally advanced breast cancer. J Clin Oncol 2: 149–151, 1984
Henderson IC, Hayes DF, Come S, Harris JR, Canellos G: New agents and new medical treatments for advanced breast cancer. Sem Oncol 14: 34–64, 1987
Valagussa P, Brambilla C, Bonadonna G: Chemotherapy of advanced disease.In Hoogstraten B, Burn I, Bloom HJG (eds) Breast Cancer. Springer Verlag, 1989, pp 233–256
De Lena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G: Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1: 53–59, 1978
De Lena M, Varini M, Zucali R, Rovini D, Viganotti G, Valagussa P, Veronesi U, Bonadonna G: Multimodal treatment for locally advanced breast cancer. Cancer Clin Trials 4: 229–236, 1981
Valagussa P, Zambetti M, Bignami P, De Lena M, Varini M, Zucali R, Rovini D, Bonadonna G: T3b-T4 breast cancer: factors affecting results in combined modality treatment. Clin Expl Metastasis 1: 191–202, 1983
Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958
Peto R, Pike MC, Armitage P, Brewslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1–39, 1977
Cox DR: Regression models and life tables. J Roy Statist Soc B 34: 187–220, 1972
Miller RC: Survival Analysis. John Wiley & Sons, New York, 1981
Baclesse F: Roentgen therapy as sole method of treatment of cancer of the breast. Am J Roent 62: 311–319, 1949
Fletcher GH: Local results of irradiation in the primary management of localized breast cancer. Cancer 29: 545–551, 1971
Sheldon T, Hayes DF, Cady B, Parker L, Osteen R, Silver B, Recht A, Come S, Henderson IC, Harrys JR: Primary radiation therapy for locally advanced breast cancer. Cancer 60: 1219–1225, 1987
Zucali R, Uslenghi C, Kenda R, Bonadonna G: Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer 37: 1422–1431, 1976
Bonadonna G, Valagussa P: The contribution of medicine to the primary treatment of breast cancer. Cancer Res 48: 2314–2324, 1988
Swain SM, Sorace RA, Bagley CS, Danforth DN Jr, Bader J, Wesley MN, Steinberg SM, Lippman ME: Neoadjuvant chemotherapy in combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47: 3889–3894, 1987
Hortobagyi GN, Buzdar AU, Montague E, Romsdahl M: Neoadjuvant chemotherapy for primary breast cancer.In Jacquillat C et al. (eds) Neoadjuvant chemotherapy. Colloque INSERM/J-Libbey Eurotext Ltd, London-Paris, 1986, pp 189–196
Chauvergne J, Durant M, Richard P, Avril A, Hoerni B, Lagarde C: Combination treatment of localized breast cancers with a high risk of metastatic disease. The results of a prospective controlled study. J Gynecol Obstet Biol Reprod 10: 75–85, 1981
Jacquillat C, Baillet F, Weil M, Auclerc G, Housset M, Auclerc MF, Sellami M, Jindani A, Thill L, Soubrane C, Khayat D: Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA–IIIB). Cancer 61: 1977–1982, 1988
Perloff M, Lesnick CJ, Korzun A, Chu F, Holland JF, Thirlwell MP, Ellison RR, Carey RW, Leone L, Weinberg V, Rice MA, Wood WC: Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B Study. J Clin Oncol 6: 261–269, 1988
Ragaz J, Manji M, Olivotto I, Basco V, Worth A, Knowling M, Plenderleith I, Spinelli J: Role of mastectomy in preoperative (neoadjuvant) combined modality therapy of locally advanced breast cancer. Proc Am Soc Clin Oncol 6: 55, 1987 (Abstr)
De Vita VT Jr: The James Ewing Lecture. The relationship between tumor mass and resistance to chemotherapy: implications for surgical adjuvant treatment of cancer. Cancer 51: 1209–1220, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Valagussa, P., Zambetti, M., Bonadonna, G. et al. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Tr 15, 137–147 (1990). https://doi.org/10.1007/BF01806351
Issue Date:
DOI: https://doi.org/10.1007/BF01806351